Epstein Secrets

ing on `unsustainable drug prices' concludes — Hybrid hearing on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human

ers from detection and arrest enabled the entry of enormous amounts of dangerous drugs into the United States." DEA Special Agent in Charge in Miami Keith Weis said that "the rewards for information leading to their whereabouts and capture will add another significant level of pressure" to bring them to jus

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

ers from detection and arrest enabled the entry of enormous amounts of dangerous drugs into the United States." DEA Special Agent in Charge in Miami Keith Weis said that "the rewards for information leading to their whereabouts and capture will add another significant level of pressure" to bring them to ju

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

rs from detection and arrest enabled the entry of enormous amounts of dangerous drugs into the United States." DEA Special Agent in Charge in Miami Keith Weis said that "the rewards for information leading to their whereabouts and capture will add another significant level of pressure" to bring them to jus

ng on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

rs from detection and arrest enabled the entry of enormous amounts of dangerous drugs into the United States." DEA Special Agent in Charge in Miami Keith Weis said that "the rewards for information leading to their whereabouts and capture will add another significant level of pressure" to bring them to jus